Routti Jorma 4
4 · FIBROGEN INC · Filed Jun 12, 2018
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Routti Jorma
Director
Transactions
- Exercise/Conversion
Common Stock
2018-06-11$9.78/sh+6,000$58,650→ 137,540 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-06-11−6,000→ 0 totalExercise: $9.78Exp: 2023-04-17→ Common Stock (6,000 underlying) - Sale
Common Stock
2018-06-11$57.48/sh−6,000$344,880→ 131,540 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $57.05 to $58.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.